TY - JOUR
T1 - A randomized clinical trial of continuous-flow nitrous oxide and midazolam for sedation of young children during laceration repair
AU - Luhmann, Jan D.
AU - Kennedy, Robert M.
AU - Porter, Fran Lang
AU - Miller, J. Philip
AU - Jaffe, David M.
PY - 2001
Y1 - 2001
N2 - Study objective: To compare the efficacy and complication profile of oral midazolam therapy and continuous-flow 50% nitrous oxide in alleviating anxiety during laceration repair in children 2 to 6 years old. Methods: We conducted a prospective, randomized clinical trial using 4 study groups who required laceration repair: (1) children who received standard care alone, which included comforting and topical anesthesia augmented with injected lidocaine if needed; (2) children who received standard care and oral midazolam; (3) children who received standard care and nitrous oxide; and (4) children who received standard care, oral midazolam, and nitrous oxide. Videotapes were blindly scored using the Observational Scale of Behavioral Distress-Revised (OSBD-R) to assess distress during baseline, wound cleaning, lidocaine injecting, suturing, and recovery. Adverse effects were noted during suturing and by parent questionnaires completed 24 hours after suturing and at suture removal. OSBD-R data were analyzed using repeated-measures analysis of variance. Adverse effect data were analyzed using categorical models. Results: Two hundred four subjects were enrolled (midazolam plus nitrous oxide 52, midazolam 51, nitrous oxide 51, standard care 50; mean patient age was 4.1 years; 66% were boys). Mean OSBD-R scores were lower for groups that received nitrous oxide during wound cleaning by 2.2 points (95% confidence interval [Cl] 1.1 to 3.2), lidocaine injecting by 2.5 points (95% Cl 1.4 to 3.5), and suturing by 2.9 (95% Cl 1.8 to 3.9). Adverse effects occurred more frequently, and recovery times were longer for groups that received midazolam. Conclusion: For facial suturing in 2- to 6-year-old children, regimens including continuous-flow nitrous oxide were more effective in reducing distress, and had fewer adverse effects and shorter recovery times than midazolam.
AB - Study objective: To compare the efficacy and complication profile of oral midazolam therapy and continuous-flow 50% nitrous oxide in alleviating anxiety during laceration repair in children 2 to 6 years old. Methods: We conducted a prospective, randomized clinical trial using 4 study groups who required laceration repair: (1) children who received standard care alone, which included comforting and topical anesthesia augmented with injected lidocaine if needed; (2) children who received standard care and oral midazolam; (3) children who received standard care and nitrous oxide; and (4) children who received standard care, oral midazolam, and nitrous oxide. Videotapes were blindly scored using the Observational Scale of Behavioral Distress-Revised (OSBD-R) to assess distress during baseline, wound cleaning, lidocaine injecting, suturing, and recovery. Adverse effects were noted during suturing and by parent questionnaires completed 24 hours after suturing and at suture removal. OSBD-R data were analyzed using repeated-measures analysis of variance. Adverse effect data were analyzed using categorical models. Results: Two hundred four subjects were enrolled (midazolam plus nitrous oxide 52, midazolam 51, nitrous oxide 51, standard care 50; mean patient age was 4.1 years; 66% were boys). Mean OSBD-R scores were lower for groups that received nitrous oxide during wound cleaning by 2.2 points (95% confidence interval [Cl] 1.1 to 3.2), lidocaine injecting by 2.5 points (95% Cl 1.4 to 3.5), and suturing by 2.9 (95% Cl 1.8 to 3.9). Adverse effects occurred more frequently, and recovery times were longer for groups that received midazolam. Conclusion: For facial suturing in 2- to 6-year-old children, regimens including continuous-flow nitrous oxide were more effective in reducing distress, and had fewer adverse effects and shorter recovery times than midazolam.
UR - http://www.scopus.com/inward/record.url?scp=0035154876&partnerID=8YFLogxK
U2 - 10.1067/mem.2001.112003
DO - 10.1067/mem.2001.112003
M3 - Article
C2 - 11145766
AN - SCOPUS:0035154876
SN - 0196-0644
VL - 37
SP - 20
EP - 27
JO - Annals of emergency medicine
JF - Annals of emergency medicine
IS - 1
ER -